KOSDAQ · Healthcare · ₩105B
₩4,475-1.10%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 10.7% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“이번 분기, 신약 개발에서 생산과 사업화로 발을 넓혔어요.”
In the company's words · 2026 2분기 filing